Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Jasper Therapeutics Inc.

    NASDAQ: JSPR · Real-Time Price · USD
    5.54
    -0.03 (-0.54%)
    At close: Jun 13, 2025, 3:59 PM
    5.50
    -0.63%
    After-hours: Jun 13, 2025, 07:49 PM EDT

    Jasper Therapeutics Statistics

    Share Statistics

    Jasper Therapeutics has 15.02M shares outstanding. The number of shares has increased by -0.42% in one year.

    Shares Outstanding

    n/a
    		 15.02M

    Shares Change (YoY)

    n/a
    		 -0.42%

    Shares Change (QoQ)

    n/a
    		 0.14%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 12.59M

    Failed to Deliver (FTD) Shares

    n/a
    		 109

    FTD / Avg. Volume

    n/a
    		 0.06%

    Short Selling Information

    The latest short interest is 1.73M, so 11.49% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.73M

    Short % of Shares Out

    n/a
    		 11.49%

    Short % of Float

    n/a
    		 11.64%

    Short Ratio (days to cover)

    n/a
    		 7.95

    Valuation Ratios

    The PE ratio is -4.38 and the forward PE ratio is -1.11. Jasper Therapeutics's PEG ratio is 0.21.

    PE Ratio

    n/a
    		 -4.38

    Forward PE

    n/a
    		 -1.11

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.4

    PB Ratio

    n/a
    		 5.06

    P/FCF Ratio

    n/a
    		 -4.94

    PEG Ratio

    n/a
    		 0.21
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Jasper Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.98, with a Debt / Equity ratio of 0.03.

    Current Ratio

    n/a
    		 4.98

    Quick Ratio

    n/a
    		 4.98

    Debt / Equity

    n/a
    		 0.03

    Debt / EBITDA

    n/a
    		 -0.03

    Debt / FCF

    n/a
    		 -0.03

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,113,578.12

    Employee Count

    n/a
    		 64

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -1.49M

    Effective Tax Rate

    n/a
    		 2.05%

    Stock Price Statistics

    The stock price has increased by -77.86% in the last 52 weeks. The beta is 2.73, so Jasper Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.73

    52-Week Price Change

    n/a
    		 -77.86%

    50-Day Moving Average

    n/a
    		 4.85

    200-Day Moving Average

    n/a
    		 12.4

    Relative Strength Index (RSI)

    n/a
    		 55.27

    Average Volume (20 Days)

    n/a
    		 195,120

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -76.24M

    Net Income

    n/a
    		 -71.27M

    EBITDA

    n/a
    		 -71.39M

    EBIT

    n/a
    		 -72.76M

    Earnings Per Share (EPS)

    n/a
    		 -4.89
    Full Income Statement

    Balance Sheet

    The company has 71.64M in cash and 1.81M in debt, giving a net cash position of 69.82M.

    Cash & Cash Equivalents

    n/a
    		 71.64M

    Total Debt

    n/a
    		 1.81M

    Net Cash

    n/a
    		 69.82M

    Retained Earnings

    n/a
    		 -240.87M

    Total Assets

    n/a
    		 57.6M

    Working Capital

    n/a
    		 40.84M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -62.6M and capital expenditures -552K, giving a free cash flow of -63.15M.

    Operating Cash Flow

    n/a
    		 -62.6M

    Capital Expenditures

    n/a
    		 -552K

    Free Cash Flow

    n/a
    		 -63.15M

    FCF Per Share

    n/a
    		 -4.33
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    JSPR does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for JSPR is $65, which is 1073.3% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $65

    Price Target Difference

    n/a
    		 1073.3%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 10
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jan 4, 2024. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Jan 4, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -3.08

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist